- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
CLSN Market Currents
more »
-
February 16 Shares of Celsion (CLSN) soar 15.4% in premarket trading after the firm catches a Buy rating along with positive comments from Brean Murray on the strength of encouraging data it expects to see released on Celsion's ThermoDox treatment later this year. Analysts at Brean set a PT of $7 for CLSN - marking 267% upside potential.
Comment![On the Move, Healthcare]
CLSN in Focus
more »
CLSN Related Articles
more »
CLSN News
more »
Currently, there are no news on CLSN.
CLSN Press Releases and Filings
more »
-
Marketwire (May 15, 2012)
-
Marketwire (May 14, 2012)
-
Marketwire (May 8, 2012)
-
Marketwire (May 7, 2012)
-
Marketwire (May 1, 2012)
CLSN Latest Transcript
more »
Currently, there are no transcripts for CLSN.
CLSN Cramer
more »
Currently, there are no Cramer articles on CLSN.
CLSN Instablog posts
more »
CLSN vs. ETF Alternatives
Company Description
Currently, there's no company description for CLSN.
